Athos Therapeutics Inc. is a clinical-stage biotechnology company developing AI-based precision small molecule therapeutics for patients with inflammatory bowel disease and other autoimmune and chronic inflammatory diseases, integrating human clinical and molecular datasets with computational medicinal chemistry and machine learning. It also offers Athos Omics AI, a software platform for analyzing multi-omics data across industries such as drug, agriculture, food, beverage, and cosmetics development.